Innovation in cancer startups is driven by the urgent need for more effective treatments, early detection methods, and personalized medicine. Advances in biotechnology and data analytics have opened new avenues for startups to explore novel solutions. Moreover, the increasing availability of genomic data and improvements in artificial intelligence have enabled startups to develop targeted therapies and predictive diagnostic tools.
